Cargando…

Topography of Simulated Intestinal Equilibrium Solubility

[Image: see text] Oral administration of a solid dosage form requires drug dissolution in the gastrointestinal tract before absorption. Solubility is a key factor controlling dissolution, and it is recognized that, within the intestinal tract, this is influenced by the luminal fluid pH, amphiphile c...

Descripción completa

Detalles Bibliográficos
Autores principales: Dunn, Claire, Perrier, Jeremy, Khadra, Ibrahim, Wilson, Clive G., Halbert, Gavin W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2019
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505523/
https://www.ncbi.nlm.nih.gov/pubmed/30848917
http://dx.doi.org/10.1021/acs.molpharmaceut.8b01238
_version_ 1783416773705465856
author Dunn, Claire
Perrier, Jeremy
Khadra, Ibrahim
Wilson, Clive G.
Halbert, Gavin W.
author_facet Dunn, Claire
Perrier, Jeremy
Khadra, Ibrahim
Wilson, Clive G.
Halbert, Gavin W.
author_sort Dunn, Claire
collection PubMed
description [Image: see text] Oral administration of a solid dosage form requires drug dissolution in the gastrointestinal tract before absorption. Solubility is a key factor controlling dissolution, and it is recognized that, within the intestinal tract, this is influenced by the luminal fluid pH, amphiphile content, and composition. Various simulated intestinal fluid recipes have been introduced to mimic this behavior and studied using a range of different experimental techniques. In this article, we have measured equilibrium solubility utilizing a novel four component mixture design (4CMD) with biorelevant amphiphiles (bile salt, phospholipid, oleate, and monoglyceride) within a matrix of three pH values (5, 6, and 7) and total amphiphile concentrations (11.7, 30.6, and 77.5 mM) to provide a topographical and statistical overview. Three poorly soluble drugs representing acidic (indomethacin), basic (carvedilol), and neutral (fenofibrate) categories have been studied. The macroscopic solubility behavior agrees with literature and exhibits an overall increasing solubility from low pH and total amphiphile concentration to high pH and total amphiphile concentration. Within the matrix, all three drugs display different topographies, which can be related to the statistical effect levels of the individual amphiphiles or amphiphile interactions on solubility. The study also identifies previously unreported three and four way factor interactions notably between bile salt, phospholipid, pH, and total amphiphile concentration. In addition, the results also reveal that solubility variability is linked to the number of amphiphiles and the respective ratios in the measurement fluid, with the minimum variation present in systems containing all four amphiphiles. The individual 4CMD experiments within the matrix can be linked to provide a possible intestinal solubility window for each drug that could be applied in PBPK modeling systems. Overall the approach provides a novel overview of intestinal solubility topography along with greater detail on the impact of the various factors studied; however, each matrix requires 351 individual solubility measurements. Further studies will be required to refine the experimental protocol in order the maximize information garnered while minimizing the number of measurements required.
format Online
Article
Text
id pubmed-6505523
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-65055232019-05-23 Topography of Simulated Intestinal Equilibrium Solubility Dunn, Claire Perrier, Jeremy Khadra, Ibrahim Wilson, Clive G. Halbert, Gavin W. Mol Pharm [Image: see text] Oral administration of a solid dosage form requires drug dissolution in the gastrointestinal tract before absorption. Solubility is a key factor controlling dissolution, and it is recognized that, within the intestinal tract, this is influenced by the luminal fluid pH, amphiphile content, and composition. Various simulated intestinal fluid recipes have been introduced to mimic this behavior and studied using a range of different experimental techniques. In this article, we have measured equilibrium solubility utilizing a novel four component mixture design (4CMD) with biorelevant amphiphiles (bile salt, phospholipid, oleate, and monoglyceride) within a matrix of three pH values (5, 6, and 7) and total amphiphile concentrations (11.7, 30.6, and 77.5 mM) to provide a topographical and statistical overview. Three poorly soluble drugs representing acidic (indomethacin), basic (carvedilol), and neutral (fenofibrate) categories have been studied. The macroscopic solubility behavior agrees with literature and exhibits an overall increasing solubility from low pH and total amphiphile concentration to high pH and total amphiphile concentration. Within the matrix, all three drugs display different topographies, which can be related to the statistical effect levels of the individual amphiphiles or amphiphile interactions on solubility. The study also identifies previously unreported three and four way factor interactions notably between bile salt, phospholipid, pH, and total amphiphile concentration. In addition, the results also reveal that solubility variability is linked to the number of amphiphiles and the respective ratios in the measurement fluid, with the minimum variation present in systems containing all four amphiphiles. The individual 4CMD experiments within the matrix can be linked to provide a possible intestinal solubility window for each drug that could be applied in PBPK modeling systems. Overall the approach provides a novel overview of intestinal solubility topography along with greater detail on the impact of the various factors studied; however, each matrix requires 351 individual solubility measurements. Further studies will be required to refine the experimental protocol in order the maximize information garnered while minimizing the number of measurements required. American Chemical Society 2019-03-08 2019-05-06 /pmc/articles/PMC6505523/ /pubmed/30848917 http://dx.doi.org/10.1021/acs.molpharmaceut.8b01238 Text en Copyright © 2019 American Chemical Society This is an open access article published under a Creative Commons Attribution (CC-BY) License (http://pubs.acs.org/page/policy/authorchoice_ccby_termsofuse.html) , which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited.
spellingShingle Dunn, Claire
Perrier, Jeremy
Khadra, Ibrahim
Wilson, Clive G.
Halbert, Gavin W.
Topography of Simulated Intestinal Equilibrium Solubility
title Topography of Simulated Intestinal Equilibrium Solubility
title_full Topography of Simulated Intestinal Equilibrium Solubility
title_fullStr Topography of Simulated Intestinal Equilibrium Solubility
title_full_unstemmed Topography of Simulated Intestinal Equilibrium Solubility
title_short Topography of Simulated Intestinal Equilibrium Solubility
title_sort topography of simulated intestinal equilibrium solubility
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505523/
https://www.ncbi.nlm.nih.gov/pubmed/30848917
http://dx.doi.org/10.1021/acs.molpharmaceut.8b01238
work_keys_str_mv AT dunnclaire topographyofsimulatedintestinalequilibriumsolubility
AT perrierjeremy topographyofsimulatedintestinalequilibriumsolubility
AT khadraibrahim topographyofsimulatedintestinalequilibriumsolubility
AT wilsoncliveg topographyofsimulatedintestinalequilibriumsolubility
AT halbertgavinw topographyofsimulatedintestinalequilibriumsolubility